Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xian-Jun Yu
Observed names:
Xian-jun Yu,
XianJun Yu
Institution:
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
ORCID:
0000-0003-2187-5204
Observed ORCID:
0000-0003-2187-5204
OpenAlex ID:
A5100736397
The platelet pannexin 1-IL-1β axis orchestrates pancreatic ductal adenocarcinoma invasion and metastasis
2023
·
Hao Li
, Wang Jiang
, et al.
·
Oncogene
·
18
PDF
G3BP2 promotes tumor progression and gemcitabine resistance in PDAC via regulating PDIA3-DKC1-hENT in a stress granules-dependent manner
2024
·
Fa-liang Xing
, Bo-rui Li
, et al.
·
Acta Pharmacologica Sinica
·
10
ASO Author Reflections: Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma
2018
·
Shi-Rong Zhang
, Hao Li
, et al.
·
Annals of Surgical Oncology
·
3
Impact of different surgical approaches on prognosis in patients with pancreatic neck cancer: A retrospective cohort study
2026
·
Ming-Jian Ma
, He Cheng
, et al.
·
World Journal of Clinical Oncology
PDF
Abstract CT146: Sequential treatment with surufatinib combined with gemcitabine and nab-paclitaxel (AG) or AG alone as first-line therapy for locally advanced or metastatic pancreatic ductal adenocarcinoma (mPDAC) after 6 weeks of AG induction therapy: A two-cohort, exploratory phase II study
2026
·
Jialin Li
, Miaoyan Wei
, et al.
·
Cancer Research
Show more works
View as search
Works count:
5
Citation count:
31
H-index:
3
I10-index:
2
Year
Topic
Type